W. Richey Neuman
Keine laufenden Positionen mehr
Profil
W.
Richey Neuman worked as an Assistant Professor at Perelman School of Medicine from 1997 to 2005.
He then worked as an Executive Director-Vaccines at Pfizer Inc. from 2005 to 2010.
After that, he worked as a Vice President-Medical Affairs at Teva Pharmaceuticals USA, Inc. and as a Vice President & Head-Medical Affairs at Hyperion Therapeutics, Inc. He also worked as a Medical Director at the University of Pennsylvania.
Neuman's education includes an undergraduate degree from Stanford University and a graduate degree from the University of California, Berkeley.
Ehemalige bekannte Positionen von W. Richey Neuman
| Unternehmen | Position | Ende |
|---|---|---|
| PORTOLA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
| PFIZER, INC. | Corporate Officer/Principal | 01.01.2010 |
| Perelman School of Medicine | Corporate Officer/Principal | 01.01.2005 |
| University of Pennsylvania | Corporate Officer/Principal | - |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | - |
Ausbildung von W. Richey Neuman
| Stanford University | Undergraduate Degree |
| University of California, Berkeley | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Hyperion Therapeutics, Inc.
 Hyperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Hyperion Therapeutics, Inc. developed and commercialized pharmaceutical products. The company was founded by Mark Blumling and Christopher Eugene Rivera on November 1, 2006 and headquartered in Brisbane, CA. | Health Technology |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
